Divyansh Agarwal (@divyansh_aga) 's Twitter Profile
Divyansh Agarwal

@divyansh_aga

Surgeon-Scientist in-training @MGHSurgery | MD-PhD @Penn | BS-MS @Yale | Statistics & Computational Biology Enthusiast | History of Medicine | Journalism

ID: 1024680358313422848

calendar_today01-08-2018 15:36:49

105 Tweet

2,2K Followers

1,1K Following

Swati Sonal (@dr_swatisonal) 's Twitter Profile Photo

A beautifully penned thought-provoking essay by Dr Divyansh Agarwal on #OurNamesBelong! Thank you on behalf of everyone who feel seen and heard through your writing!

CMAJ (@cmaj) 's Twitter Profile Photo

What's in a name? Identity, it turns out. Divyansh Agarwal shares how learning to pronounce a patient's or a colleague's name is vital to engendering respect, trust and collegiality: cmaj.ca/lookup/doi/10.… #MedTwitter

What's in a name? Identity, it turns out.

<a href="/divyansh_aga/">Divyansh Agarwal</a> shares how learning to pronounce a patient's or a colleague's name is vital to engendering respect, trust and collegiality: cmaj.ca/lookup/doi/10.…
#MedTwitter
Charu Paranjape (@charuparanjape) 's Twitter Profile Photo

Registration for the in-person ( including limited hands-on spots) and livestream virtual options open for the 2022 Harvard Minimally Invasive and Novel Therapeutics conference!! Great faculty; keynote speakers! advances.massgeneral.org/digestive-heal…

Registration for the in-person ( including limited hands-on spots) and livestream virtual options open for the 2022 Harvard Minimally Invasive and Novel Therapeutics conference!!  Great faculty; keynote speakers! advances.massgeneral.org/digestive-heal…
Kemper Complement Lab (@ckemperlab) 's Twitter Profile Photo

Hi all. We're happy to share our latest paper, just published in Cell Reports. We developed a scRNA-seq pathway analysis package and applied it to look at T cell activation in vitro and in tissue. Here's the paper: cell.com/action/showPdf….

Hi all. We're happy to share our latest paper, just published in <a href="/CellReports/">Cell Reports</a>. We developed a scRNA-seq pathway analysis package and applied it to look at T cell activation in vitro and in tissue. Here's the paper: cell.com/action/showPdf….
Kemper Complement Lab (@ckemperlab) 's Twitter Profile Photo

You can find the SCPA R package here: jackbibby1.github.io/SCPA/. It was a big collaborative work with Nancy Zhang and Divyansh Agarwal, and thanks to everyone involved (-- people on twitter: @AfzaliBehdad, Tilo Freiwald, Nicolas Merle)

Sharna Jamadar (@sharnajamadar) 's Twitter Profile Photo

Great paper linking connectivity to synaptic & neuronal density, as well as cerebral metabolic rate of glucose (CMRGLC). doi.org/10.1093/cercor…

Molecular Therapy (@moltherapy) 's Twitter Profile Photo

Modulation of the gut microbiota engages antigen cross-presentation to enhance antitumor effects of CAR T cell immunotherapy dlvr.it/Shqf8b

JAMA Network Open (@jamanetworkopen) 's Twitter Profile Photo

Personalized scrub caps help reduce role and name misidentification among surgical trainees. Cloth-based personalized caps are also associated with reduced delays in patient care arising from misidentification. ja.ma/45H0LUm Mass General Surgery Divyansh Agarwal

Boateng (@bkubi5) 's Twitter Profile Photo

Fantastic work by Divyansh Agarwal and Mass General Surgery team today in JAMA. A tool as simple as personalized scrub caps may decrease provider role/name misidentification. Extra points if you’re able to make them look as good as he did… jamanetwork.com/journals/jaman…

MGH Center for the Environment and Health (@mghenvironment) 's Twitter Profile Photo

🎧New podcast episode! Dr. Divyansh Agarwal, MGH surgeon-scientist discusses bringing sustainability to the operating room along with his recent work on reusable vs. single use scrub caps. podcastics.com/episode/267302… Divyansh Agarwal MassGeneral News Mass General Surgery MassGeneral Medicine

Snigdha Gulati (@gulatisnigdha) 's Twitter Profile Photo

Key insights uncovered: By using Mark Cuban Cost Plus Drug Company pricing as a benchmark, our research reveals $8.6 billion in potential Medicare Part D savings! The key? Addressing systemic inefficiencies in drug pricing. Mohak Gupta & Divyansh Agarwal link.springer.com/article/10.100…

Key insights uncovered: By using Mark Cuban Cost Plus Drug Company pricing as a benchmark, our research reveals $8.6 billion in potential Medicare Part D savings! 
The key? Addressing systemic inefficiencies in drug pricing. 
<a href="/MohakGuptaMD/">Mohak Gupta</a> &amp; <a href="/divyansh_aga/">Divyansh Agarwal</a> 
link.springer.com/article/10.100…